VALENTINO DEPALMA: Open Payments
NPI 1942954474 · ALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 25 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $78 |
| ABBVIE INC. | 4 | $78 |
| Novo Nordisk Inc | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Lilly USA, LLC | 2 | $35 |
| Exact Sciences Corporation | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $29 |
| Recor Medical Inc | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| PFIZER INC. | 1 | $19 |
Products named: Kerendia, QULIPTA, MOUNJARO, Cologuard Collection Kit, VRAYLAR, AIRSUPRA, Auvelity, Wegovy.
Industry payments across TX — which companies pay providers there.
